Skip to the content
Altai Oncology - Softwarelogo darklogo light
  • Library
  • Articles
  • Patient Education
  • F.A.Q.
  • Contact Us
Altai Oncology - Softwarelogo darklogo light
Pancreatic Cancer

New Reference: Neoadjuvant FOLFIRNOX for Pancreatic Cancer

Ulas D. Bayraktar, MD
2025-04-07
Non-Small Cell Lung Cancer Pancreatic Cancer

New Drug: Zenocutuzumab for advanced NRG1 fusion positive NSCLC and Pancreatic Cancer

Ulas D. Bayraktar, MD
2024-12-06
Pancreatic Cancer

New Protocol: Nimotuzumab Plus Gemcitabine for K-Ras Wild-Type Locally Advanced or Metastatic Pancreatic Cancer

Ulas D. Bayraktar, MD
2023-06-07
Pancreatic Cancer

New Indication: Sotorasib in kRAS G12C Mutant Pancreatic Cancer

Ulas D. Bayraktar, MD
2023-03-15
  • Library
  • F.A.Q.
  • Contact Us

Privacy Policy

Altai, Inc (USA)

30 N Gould St, Ste 6801

Sheridan, WY, 82801, USA

Phone: +1 (978) 393 0042

Altay Tıp Sağlık Yazılım AŞ (Türkiye)

Mutlukent Mah Manuk Bey Sk No: 4

Çankaya, Ankara, 06800, Türkiye

Phone: +90 (312) 911 5735

Our Terms & Privacy Policy

Copyright - 2024 - Altai Inc - All rights reserved

Back to top Drag
  • Library
  • Articles
  • Patient Education
  • F.A.Q.
  • Contact Us

jghghjghjghhgj